[1]
|
Baman, J.R. and Ahmad, F.S. (2020) Heart Failure. JAMA, 324, 1015. https://doi.org/10.1001/jama.2020.13310
|
[2]
|
Andrade, J., Khairy, P., Dobrev, D., et al. (2014) The Clinical Profile and Pathophysiology of Atrial Fibrillation: Relationships among Clinical Features, Epidemiology, and Mechanisms. Cir-culation Research, 114, 1453-1468.
https://doi.org/10.1161/CIRCRESAHA.114.303211
|
[3]
|
Goette, A., Honeycutt, C. and Langberg, J.J. (1996) Electrical Remodeling in Atrial Fibrillation. Time Course and Mechanisms. Circulation, 94, 2968-2974. https://doi.org/10.1161/01.CIR.94.11.2968
|
[4]
|
Franklin, S.S., Gustin, W., Wong, N.D., Larson, M.G., Weber, M.A., Kannel, W.B. and Levy, D. (1997) Hemodynamic Patterns of Age-Related Changes in Blood Pressure. The Framingham Heart Study. Circulation, 96, 308-315.
https://doi.org/10.1161/01.CIR.96.1.308
|
[5]
|
Chung, M.K., Martin, D.O., Sprecher, D., Wazni, O., Kanderian, A., Carnes, C.A., Bauer, J.A., Tchou, P.J., Niebauer, M.J., Natale, A. and Van Wagoner, D.R. (2001) C-Reactive Protein Elevation in Patients with Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation. Circula-tion, 104, 2886-2891.
https://Doi.Org/10.1161/Hc4901.101760
|
[6]
|
Maisel, W.H. and Stevenson, L.W. (2003) Atrial Fibrillation in Heart Failure: Epidemiology, Pathophysiology, and Rationale for Therapy. The American Journal of Cardiology, 91, 2-8. https://doi.org/10.1016/S0002-9149(02)03373-8
|
[7]
|
夏文芳, 于胜波, 赵庆彦, 等. 心房颤动对慢性收缩性心力衰竭患者和射血分数正常心力衰竭患者预后的影响[J]. 中国心脏起搏与心电生理杂志, 2014, 28(5): 423-426.
|
[8]
|
Zhao, L., Wang, W.Y.S. and Yang, X. (2018) Anticoagulation in Atrial Fibrillation with Heart Failure. Heart Failure Reviews, 23, 563-571. https://doi.org/10.1007/s10741-018-9693-0
|
[9]
|
Zhang, R., Mesquita, T., Cho, J.H., Li, C., Sanchez, L., Holm, K., Akhmerov, A., Liu, W., Li, Y., Ibrahim, A.G. and Cingolani, E. (2023) Sys-temic Delivery of Extracellular Vesicles Attenuates Atrial Fibrillation in Heart Failure with Preserved Ejection Fraction. JACC: Clinical Electrophysiology, 9, 147-158.
https://doi.org/10.1016/j.jacep.2022.09.012
|
[10]
|
Hanna, A. and Frangogiannis, N.G. (2020) Inflammatory Cyto-kines and Chemokines as Therapeutic Targets in Heart Failure. Cardiovascular Drugs and Therapy, 34, 849-863. https://doi.org/10.1007/s10557-020-07071-0
|
[11]
|
Paulus, W.J. (2023) Paving the Road for Interleukin-6 Inhibition in Heart Failure with Preserved Ejection Fraction. JACC: Heart Failure. (In Press) https://doi.org/10.1016/j.jchf.2023.06.032
|
[12]
|
Benz, A.P., Aeschbacher, S., Krisai, P., Moschovitis, G., Blum, S., Meyre, P., Blum, M.R., Rodondi, N., Di Valentino, M., Kobza, R., De Perna, M.L., Bonati, L.H., Beer, J.H., Kühne, M., Osswald, S., Conen, D. and BEAT-AF, Swiss-AF Investigators (2021) Biomarkers of Inflammation and Risk of Hospitalization for Heart Failure in Patients with Atrial Fibrillation. Journal of the American Heart Association, 10, e019168. https://doi.org/10.1161/JAHA.120.019168
|
[13]
|
Markousis-Mavrogenis, G., Tromp, J., Ouwerkerk, W., Devalaraja, M., Anker, S.D., Cleland, J.G., Dickstein, K., Filippatos, G.S., van der Harst, P., Lang, C.C., Metra, M., Ng, L.L., Ponikowski, P., Samani, N.J., Zannad, F., Zwinderman, A.H., Hillege, H.L., van Veldhuisen, D.J., Kakkar, R., Voors, A.A. and van der Meer, P. (2019) The Clinical Significance of Interleukin-6 in Heart Failure: Results from the BIOSTAT-CHF Study. European Journal of Heart Failure, 21, 965-973. https://doi.org/10.1002/ejhf.1482
|
[14]
|
徐标, 孙璇. 炎症在心肌损伤和修复中的作用[J]. 临床心血管病杂志, 2018, 34(7): 633-635.
https://doi.org/10.13201/j.issn.1001-1439.2018.07.001
|
[15]
|
Chi, R., Shan, X., Guan, C., Yang, H., Wang, X., Li, B. and Zhang, Q. (2023) Association between Systemic Inflammatory Response Index and Left Ventricular Remodeling and Systolic Dysfunction in Atrial Fibrillation Patients. BMC Cardiovascular Disorders, 23, Article No. 377. https://doi.org/10.1186/s12872-023-03403-8
|
[16]
|
Kutlay, Ö., Yalım, Z. and Aktan, A.K. (2023) Inflammatory Bi-omarkers Derived from Whole Blood Cell Count in Atrial Fibrillation Patients. Kardiologiia, 63, 50-55. https://doi.org/10.18087/cardio.2023.8.n2336
|
[17]
|
Lotfi, M.E., Pezeshki, P.S. and Rezaei, N. (2023) The Role of Interleukins in Pathogenesis and Prognosis of Atrial Fibrillation. Expert Review of Clinical Immunology, 19, 585-597. https://doi.org/10.1080/1744666X.2023.2196013
|
[18]
|
Yu, Y., Fan, Z., Han, Y., Sun, X., Dong, C., Liu, G., Yin, X., Liu, L., Bai, Y. and Yang, B. (2023) miR-135 Protects against Atrial Fibrillation by Suppressing Intracellular Calci-um-Mediated NLRP3 Inflammasome Activation. Journal of Cell Communication and Signaling, 17, 813-825. https://doi.org/10.1007/s12079-023-00721-6
|
[19]
|
Dridi, H., Kushnir, A., Zalk, R., Yuan, Q., Melville, Z. and Marks, A.R. (2020) Intracellular Calcium Leak in Heart Failure and Atrial Fibrillation: A Unifying Mechanism and Therapeutic Target. Nature Reviews Cardiology, 17, 732-747. https://doi.org/10.1038/s41569-020-0394-8
|